Pulling SEC filings + quote and writing the call…

PEDEVCO CORP
Next earnings Aug 12, 2026 · consensus $0.51 EPS, $41.3M rev
Last earnings +6.7% on 2026-05-14
Debt-funded merger transformed PED into a bigger but money-losing driller with a razor-thin $3.2M cash cushion — full price, real risk.
Revenue $45.8M · FY2025
PEDEVCO just remade itself. FY2025 revenue grew to $45.8M (+15.7%) and total assets ballooned to $376M (+192.8%), but that growth came entirely from the Mergers, funded by drawing $98M of a new $120M Citibank borrowing base — which is why total liabilities exploded +1,222% to $169M. The result is a company that swung from +$12.3M net income in FY2024 to a -$10.4M loss in FY2025, with operating income of -$7.86M and diluted EPS of -$2.25. D&A jumped to $18.0M as the acquired PRB/Permian assets were consolidated. This is not organic deterioration in a stable business — it's the digestion cost of a large, leveraged acquisition, and the market is being asked to pay 3.6x sales for the outcome before it has proven out.
The balance sheet is the real concern. Cash is just $3.22M (-19.7% YoY) against $64.5M of current liabilities and only $37.8M of current assets — a GAAP current ratio near 0.59. Management concedes liquidity leans on 'projected cash flow, existing cash on hand, borrowing under our A&R Credit Agreement... public or private debt or equity financings pursuant to the ATM Offering... and asset sales, farm-out arrangements.' That is a stack of external funding sources, not self-funding. The credit facility carries maintenance covenants (current ratio ≥1.0x on its own definition that includes unused commitments, leverage ≤3.0x Net Debt/EBITDAX) and mandatory hedging of 75% of PDP production for 24 months — protective for lenders, but a constraint on the equity if oil prices weaken. The $122M accumulated deficit underscores that profitable years have been the exception, not the rule.
Is PED a buy? The one-page verdict, explained →
SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $15.9M | $30.0M | $30.8M | $39.6M | $45.8M |
| Gross profit | — | — | — | — | — |
| Operating income | -$1.87M | $2.63M | $1.24M | $4.72M | -$7.86M |
| Net income | -$1.30M | $2.84M | $1.70M | $12.3M | -$10.4M |
| Diluted EPS | -$0.02 | $0.03 | $0.02 | $2.76 | -$2.25 |
| Net margin | -8.2% | 9.5% | 5.5% | 31.1% | -22.6% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Executive/board change (Item 5.02) — management transition, no financial impact disclosed
Another officer/director change (5.02) with related exhibits — leadership churn continues
New material agreement + direct financial obligation — added leverage on Citibank facility
Q1 2026 report — first full post-merger quarter with enlarged asset/debt base
Q1 2026 report — first full post-merger quarter with enlarged asset/debt base
Entered material agreement creating new debt obligation to fund development/M&A
FY2025 loss despite +16% revenue; $98M drawn on credit line, assets +193% from Mergers
FY2025 loss despite +16% revenue; $98M drawn on credit line, assets +193% from Mergers
Amended acquisition disclosure — updated pro forma/financials for the Mergers
Sources: SEC EDGAR (CIK 0001141197, latest 10-Q filed 2026-05-14) · EODHD · Proprietary analysis · as of 7/3/2026, 3:49:37 PM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 3, 2026, 11:49 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 2 open-market buys · 1 sale
| 2026-06-30 | Clark Moore Executive VP | Sell | 18.8K @ $14.67 | $276K |
| 2026-05-26-05:00 | Willsher Martyn Director | Buy | 13.4K @ $14.29 | $192K |
| 2026-05-22-05:00 | Willsher Martyn Director | Buy | 6.57K @ $14.74 | $96.9K |
| 2026-04-30-05:00 | Howie John K Director | Award | 782.00 @ $15.98 | $12.5K |
| 2026-02-27 | Crook Jody D. CHIEF COMMERCIAL OFFICER | Exercise | 45.5K | |
| 2026-02-27 | Clark Moore Executive VP | Exercise | 45.5K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median